KURA ONCOLOGY, INC. Operating Lease, Weighted Average Discount Rate, Percent
KURA ONCOLOGY, INC. (KURA) had Operating Lease, Weighted Average Discount Rate, Percent of 12.30% as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 12.30%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 12.30%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 12.30%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 12.30%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 12.30% 10-Q · filed 2026-08-12 |
| 2026-03-31 | 12.30% 10-Q · filed 2026-05-12 |
| 2025-12-31 | 12.30% 10-Q · filed 2026-08-12 |
| 2025-09-30 | 12.30% 10-Q · filed 2025-11-04 |
| 2025-06-30 | 12.20% 10-Q · filed 2025-08-07 |
| 2025-03-31 | 12.10% 10-Q · filed 2025-05-01 |
| 2024-12-31 | 11.40% 10-K · filed 2026-03-05 |
| 2024-09-30 | 11.20% 10-Q · filed 2024-11-07 |
| 2024-06-30 | 11.10% 10-Q · filed 2024-08-08 |
| 2024-03-31 | 10.60% 10-Q · filed 2024-05-02 |
| 2023-12-31 | 10.40% 10-K · filed 2025-02-28 |
| 2023-09-30 | 10.30% 10-Q · filed 2023-11-02 |
| 2023-06-30 | 5.50% 10-Q · filed 2023-08-09 |
| 2023-03-31 | 5.50% 10-Q · filed 2023-05-10 |
| 2022-12-31 | 5.50% 10-K · filed 2024-02-27 |
| 2022-09-30 | 5.50% 10-Q · filed 2022-11-03 |
| 2022-06-30 | 5.50% 10-Q · filed 2022-08-03 |
| 2022-03-31 | 5.50% 10-Q · filed 2022-05-04 |
| 2021-12-31 | 5.50% 10-K · filed 2023-02-23 |
| 2021-09-30 | 5.50% 10-Q · filed 2021-11-04 |
| 2021-06-30 | 5.50% 10-Q · filed 2021-08-05 |
| 2021-03-31 | 5.50% 10-Q · filed 2021-05-06 |
| 2020-12-31 | 5.50% 10-K · filed 2022-02-24 |
| 2020-09-30 | 5.50% 10-Q · filed 2020-11-05 |
| 2020-06-30 | 5.50% 10-Q · filed 2020-08-06 |
| 2020-03-31 | 5.60% 10-Q · filed 2020-05-04 |
| 2019-12-31 | 6.50% 10-K · filed 2021-02-24 |
| 2019-09-30 | 6.50% 10-Q · filed 2019-11-05 |
| 2019-06-30 | 6.50% 10-Q · filed 2019-08-01 |
| 2019-03-31 | 6.50% 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |